GLIMEPIRID AUROVITAS

4MG TBL NOB 30

SÚKL code 0229300
Name of the product GLIMEPIRID AUROVITAS
_MA_MEDICATION_DETAIL_INFO_MED_NAME i GLIMEPIRID AUROVITAS
Supplement 4MG TBL NOB 30
Strenght 4MG
Pharmaceutical form Tablet
Package 30
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance GLIMEPIRIDE (GLIMEPIRIDUM)
ATC group A10BB12
ATC group name GLIMEPIRID

Marketing authorisation information

Registration Number 18/ 088/17-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 30. 04. 2020
MA Holder Aurovitas Pharma Polska Sp. z o.o., Warszawa
MA Holder country POLSKO
Actual MA holder Aurovitas, spol. s r.o., Praha
Actual MA holder country ČESKÁ REPUBLIKA

Back to list